Cristina
Bohorquez Heras
Profesor/a Asociado/a en CC. de la Salud
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (27)
2024
-
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register
Seminars in Arthritis and Rheumatism, Vol. 64
-
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
European Journal of Clinical Investigation, Vol. 54, Núm. 2
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197
-
Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry
Reumatologia Clinica, Vol. 19, Núm. 9, pp. 500-506
-
Ultrasonography in the diagnosis of suspected primary Sjögren’s syndrome and concordance with salivary gland biopsy: a Spanish single-center study
Clinical Rheumatology, Vol. 42, Núm. 9, pp. 2409-2417
-
Werner syndrome as a crossroads between lipodystrophy, escleroderma-like changes and torpid ulcers in lower limbs
Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 5, pp. 362-364
2022
2021
-
Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry
Scientific Reports, Vol. 11, Núm. 1
-
Clinical management protocol for confusional syndrome in systemic lupus erythematosus
Medicine (Spain), Vol. 13, Núm. 31, pp. 1789-1792
-
Diagnostic and treatment protocol for asthenia in autoimmune diseases
Medicine (Spain), Vol. 13, Núm. 32, pp. 1856-1860
-
Protocolised odontological assessment of patients with primary Sjögren's syndrome
Reumatologia Clinica, Vol. 17, Núm. 1, pp. 25-31
-
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: Results from the COVIDSER study
RMD Open, Vol. 7, Núm. 3
2020
-
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662
-
Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry
Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 110-115
-
Hormonal Dependence and Cancer in Systemic Lupus Erythematosus
Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224
-
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: Data from the RELESSER Registry
Rheumatology (United Kingdom), Vol. 59, Núm. 8, pp. 2043-2051
-
Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: Data from the BIOBADASER III register
Arthritis Research and Therapy, Vol. 22, Núm. 1
-
Methrotexate treatment inmunomodulates abnormal cytokine expression by T CD4 lymphocytes present in DMARD-naïve rheumatoid arthritis patients
International Journal of Molecular Sciences, Vol. 21, Núm. 18, pp. 1-17